Grants Awarded in 2017

Functional Evaluation of Immunologic Checkpoint Blockade in the Therapy of Histiocytosis
Omar Abdel-Wahab, MD
Memorial Sloan Kettering Cancer Center, New York, NY USA

Project Canceled - Identifying differentiating biomarkers in an inception cohort of hyperferritinemic syndromes
Scott Canna, MD
University of Pittsburgh, Pittsburgh, PA USA

Investigating the mechanisms of cytotoxic granule exocytosis underlying hemophagocytic lymphohistiocytosis 
Shuzo Sugita, PhD
University Health Network/U of Toronto, Toronto, ON Canada

Maintenance of the IT platform of the LCH-IV Treatment Protocol Study (LCH-IVTPS)
Milen Minkov, MD, PhD
CCRI, St. Anna Kinderkrebsforschung, Vienna, Austria

MAP kinase pathway activation, DC development and expression of the LCH phenotype 
Prof. Matthew Collin
Newcastle University, Newcastle Upon Tyne, UK

Mapping the heterogeneity of Langerhans cell histiocytosis using single-cell analysis 
Florent Ginhoux, PhD
Singapore Immunology Network (SIgN) / A*STAR, Singapore

Unraveling Genetic Mysteries in Hemophagocytic Lymphohistiocytosis 
Ivan Chinn, MD
Baylor College of Medicine, Houston, TX USA



Return to Grant Awards page

Donate Now
© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 

¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: Nosotros podremos responderle tan pronto nos sea possible. Gracias!